US Stock MarketDetailed Quotes

ConMed (CNMD)

Watchlist
  • 41.570
  • -0.980-2.30%
Close Jan 16 15:59 ET
  • 41.570
  • 0.0000.00%
Post 16:28 ET
1.29BMarket Cap20.28P/E (TTM)

ConMed (CNMD) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
6.70%337.93M
3.09%342.35M
2.88%321.26M
5.00%1.31B
5.78%345.94M
3.98%316.7M
4.55%332.1M
5.69%312.27M
19.06%1.24B
30.37%327.05M
Operating revenue
6.70%337.93M
3.09%342.35M
2.88%321.26M
5.00%1.31B
5.78%345.94M
3.98%316.7M
4.55%332.1M
5.69%312.27M
19.06%1.24B
30.37%327.05M
Cost of revenue
24.76%171.81M
3.81%154.03M
2.28%143.5M
0.96%573.98M
1.88%147.6M
0.87%137.71M
0.96%148.37M
0.11%140.31M
19.88%568.5M
21.73%144.87M
Gross profit
-7.19%166.12M
2.50%188.32M
3.37%177.75M
8.40%733.03M
8.88%198.34M
6.51%179M
7.64%183.73M
10.72%171.97M
18.38%676.25M
38.16%182.18M
Operating expense
36.15%154.24M
9.91%150.16M
18.14%161.79M
-4.13%532.71M
10.50%145.85M
-17.76%113.29M
-4.64%136.62M
-3.98%136.95M
10.86%555.64M
-0.73%131.99M
Selling and administrative expenses
40.72%140.34M
11.02%136.02M
20.66%148.85M
-4.92%478.28M
12.47%132.67M
-20.40%99.73M
-5.53%122.52M
-5.17%123.36M
10.79%503.04M
-2.30%117.96M
Research and development costs
2.53%13.9M
0.28%14.14M
-4.76%12.95M
3.47%54.43M
-6.07%13.18M
8.78%13.56M
3.88%14.1M
8.41%13.59M
11.56%52.6M
14.80%14.03M
Operating profit
-81.92%11.88M
-18.99%38.16M
-54.42%15.96M
66.10%200.33M
4.61%52.5M
116.85%65.71M
71.81%47.11M
175.71%35.01M
72.16%120.6M
4,683.29%50.19M
Net non-operating interest income expense
17.79%-7.61M
18.44%-7.82M
13.63%-8.29M
6.23%-37.3M
6.81%-8.86M
7.66%-9.25M
4.04%-9.59M
6.45%-9.59M
-37.61%-39.78M
-0.65%-9.5M
Non-operating interest expense
-17.79%7.61M
-18.44%7.82M
-13.63%8.29M
-6.23%37.3M
-6.81%8.86M
-7.66%9.25M
-4.04%9.59M
-6.45%9.59M
37.61%39.78M
0.65%9.5M
Other net income (expense)
-418K
Other non- operating income (expenses)
----
---418K
----
----
----
----
----
----
----
----
Income before tax
-92.43%4.27M
-20.25%29.92M
-69.82%7.67M
101.70%163.03M
7.27%43.64M
178.36%56.46M
115.34%37.51M
940.06%25.42M
214.06%80.83M
486.06%40.68M
Income tax
-81.07%1.41M
12.74%8.5M
-71.35%1.64M
86.98%30.61M
29.89%9.89M
68.11%7.47M
104.34%7.54M
813.60%5.71M
68.41%16.37M
120.51%7.61M
Net income
-94.16%2.86M
-28.54%21.42M
-69.37%6.04M
105.44%132.42M
2.07%33.76M
209.30%48.98M
118.29%29.98M
983.51%19.71M
179.99%64.46M
24.40%33.07M
Net income continuous Operations
-94.16%2.86M
-28.54%21.42M
-69.37%6.04M
105.44%132.42M
2.07%33.76M
209.30%48.98M
118.29%29.98M
983.51%19.71M
179.99%64.46M
24.40%33.07M
Minority interest income
Net income attributable to the parent company
-94.16%2.86M
-28.54%21.42M
-69.37%6.04M
105.44%132.42M
2.07%33.76M
209.30%48.98M
118.29%29.98M
983.51%19.71M
179.99%64.46M
24.40%33.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-94.16%2.86M
-28.54%21.42M
-69.37%6.04M
105.44%132.42M
2.07%33.76M
209.30%48.98M
118.29%29.98M
983.51%19.71M
179.99%64.46M
24.40%33.07M
Basic earnings per share
-94.34%0.09
-28.87%0.69
-70.31%0.19
104.29%4.29
0.93%1.09
205.77%1.59
115.56%0.97
966.67%0.64
178.36%2.1
24.14%1.08
Diluted earnings per share
-94.27%0.09
-28.13%0.69
-69.84%0.19
108.33%4.25
2.86%1.08
214.00%1.57
123.26%0.96
950.00%0.63
176.12%2.04
22.09%1.05
Dividend per share
0.00%0.2
0.00%0.2
0.00%0.2
0.00%0.8
0.00%0.2
0.00%0.2
0.00%0.2
0.00%0.2
0.00%0.8
0.00%0.2
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 6.70%337.93M3.09%342.35M2.88%321.26M5.00%1.31B5.78%345.94M3.98%316.7M4.55%332.1M5.69%312.27M19.06%1.24B30.37%327.05M
Operating revenue 6.70%337.93M3.09%342.35M2.88%321.26M5.00%1.31B5.78%345.94M3.98%316.7M4.55%332.1M5.69%312.27M19.06%1.24B30.37%327.05M
Cost of revenue 24.76%171.81M3.81%154.03M2.28%143.5M0.96%573.98M1.88%147.6M0.87%137.71M0.96%148.37M0.11%140.31M19.88%568.5M21.73%144.87M
Gross profit -7.19%166.12M2.50%188.32M3.37%177.75M8.40%733.03M8.88%198.34M6.51%179M7.64%183.73M10.72%171.97M18.38%676.25M38.16%182.18M
Operating expense 36.15%154.24M9.91%150.16M18.14%161.79M-4.13%532.71M10.50%145.85M-17.76%113.29M-4.64%136.62M-3.98%136.95M10.86%555.64M-0.73%131.99M
Selling and administrative expenses 40.72%140.34M11.02%136.02M20.66%148.85M-4.92%478.28M12.47%132.67M-20.40%99.73M-5.53%122.52M-5.17%123.36M10.79%503.04M-2.30%117.96M
Research and development costs 2.53%13.9M0.28%14.14M-4.76%12.95M3.47%54.43M-6.07%13.18M8.78%13.56M3.88%14.1M8.41%13.59M11.56%52.6M14.80%14.03M
Operating profit -81.92%11.88M-18.99%38.16M-54.42%15.96M66.10%200.33M4.61%52.5M116.85%65.71M71.81%47.11M175.71%35.01M72.16%120.6M4,683.29%50.19M
Net non-operating interest income expense 17.79%-7.61M18.44%-7.82M13.63%-8.29M6.23%-37.3M6.81%-8.86M7.66%-9.25M4.04%-9.59M6.45%-9.59M-37.61%-39.78M-0.65%-9.5M
Non-operating interest expense -17.79%7.61M-18.44%7.82M-13.63%8.29M-6.23%37.3M-6.81%8.86M-7.66%9.25M-4.04%9.59M-6.45%9.59M37.61%39.78M0.65%9.5M
Other net income (expense) -418K
Other non- operating income (expenses) -------418K--------------------------------
Income before tax -92.43%4.27M-20.25%29.92M-69.82%7.67M101.70%163.03M7.27%43.64M178.36%56.46M115.34%37.51M940.06%25.42M214.06%80.83M486.06%40.68M
Income tax -81.07%1.41M12.74%8.5M-71.35%1.64M86.98%30.61M29.89%9.89M68.11%7.47M104.34%7.54M813.60%5.71M68.41%16.37M120.51%7.61M
Net income -94.16%2.86M-28.54%21.42M-69.37%6.04M105.44%132.42M2.07%33.76M209.30%48.98M118.29%29.98M983.51%19.71M179.99%64.46M24.40%33.07M
Net income continuous Operations -94.16%2.86M-28.54%21.42M-69.37%6.04M105.44%132.42M2.07%33.76M209.30%48.98M118.29%29.98M983.51%19.71M179.99%64.46M24.40%33.07M
Minority interest income
Net income attributable to the parent company -94.16%2.86M-28.54%21.42M-69.37%6.04M105.44%132.42M2.07%33.76M209.30%48.98M118.29%29.98M983.51%19.71M179.99%64.46M24.40%33.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -94.16%2.86M-28.54%21.42M-69.37%6.04M105.44%132.42M2.07%33.76M209.30%48.98M118.29%29.98M983.51%19.71M179.99%64.46M24.40%33.07M
Basic earnings per share -94.34%0.09-28.87%0.69-70.31%0.19104.29%4.290.93%1.09205.77%1.59115.56%0.97966.67%0.64178.36%2.124.14%1.08
Diluted earnings per share -94.27%0.09-28.13%0.69-69.84%0.19108.33%4.252.86%1.08214.00%1.57123.26%0.96950.00%0.63176.12%2.0422.09%1.05
Dividend per share 0.00%0.20.00%0.20.00%0.20.00%0.80.00%0.20.00%0.20.00%0.20.00%0.20.00%0.80.00%0.2
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More